Markt für Embolisationsspulen – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPHE100001434
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 198
Buy Now

Der Markt für Embolisationsspulen wurde im Jahr 2021 auf 1.191,78 Millionen US-Dollar geschätzt eine CAGR von 4,3 % im Zeitraum 2022-2028.     



Embolisationsspulen werden zur Behandlung von Hirn- und Herzaneurysmen und anderen blutbezogenen Erkrankungen eingesetzt. Sie werden als Alternative zur chirurgischen Embolisation eingesetzt, um die Blutversorgung des Tumors zu unterbrechen. Es wird zur Behandlung verschiedener Arten von Krankheiten wie Leberkrebs, Nierenkrebs, Aortenarterienerkrankungen, neuroendokrinen Tumoren und peripheren Gefäßerkrankungen eingesetzt.



Market Insights



Anstieg der Prävalenz von Herzaneurysmen



Kardiovaskuläre Erkrankungen (CVDs) sind Erkrankungen des Herzens und der Blutgefäße und umfassen zerebrovaskuläre Erkrankungen, koronare Herzerkrankungen, rheumatische Herzerkrankungen und andere Erkrankungen. Faktoren wie Tabakkonsum, ungesunde Ernährung und Bewegungsmangel erhöhen das Risiko für Herzinfarkte und Schlaganfälle. Herz-Kreislauf-Erkrankungen sind weltweit die häufigste Todesursache und betreffen mehr Menschen als jede andere Krankheit.



Das Herzaneurysma wird hauptsächlich durch Blockaden in der Aortenarterie verursacht, die Krankheit wird je nach Ort der Blockade in zwei Krankheiten eingeteilt. Die Blockaden sind in der Brust oder im Bauch zu sehen, die auch als thorakales Aortenaneurysma bzw. abdominales Aortenaneurysma bezeichnet werden. Die Prävalenz von Herzaneurysmen nimmt weltweit zu. Beispielsweise wird der Society for Vascular Surgery (SVS) mitgeteilt, dass jedes Jahr in den USA bei 2 Millionen Menschen ein abdominales Aortenaneurysma diagnostiziert wird. Es wird auch festgestellt, dass ein rupturiertes Bauchaortenaneurysma die 15. häufigste Todesursache im Land ist. Es ist am häufigsten bei Personen zu sehen, die älter als 55 Jahre sind.



Darüber hinaus ist das abdominale Aortenaneurysma hauptsächlich familiär bedingt Geschichte oder Erbe. Der unmittelbare Verwandte ist anfälliger für ein Bauchaortenaneurysma. Die Möglichkeit besteht darin, dass die Wahrscheinlichkeit, ein Bauchaortenaneurysma zu entwickeln, 10-mal höher ist. Und die Person könnte irgendeine Art von Aneurysma haben.



Ähnlich in Europa Laut der British Heart Foundation werden in Großbritannien jedes Jahr 5.000 Todesfälle durch gerissene Aortenaneurysmen verursacht. Diese treten am häufigsten bei Männern ab 65 Jahren auf und sind für 1 von 75 Todesfällen bei Männern dieser Altersgruppe verantwortlich. Ebenso ist der ähnliche Trend in der anderen Region auf der ganzen Welt zu beobachten. Aufgrund des Anstiegs der Prävalenz des Herzaneurysmas in den Regionen und in verschiedenen Ländern ist es daher wahrscheinlich, dass das Wachstum der Embolisationsspulen im Prognosezeitraum zunehmen wird. Daher treibt die steigende Prävalenz von Herzaneurysmen das Wachstum des voran Markt für Embolisationsspulen



Strategic Insights< /strong>



Type Insights



Basierend auf dem Typ ist der weltweite Markt für Embolisationsspulen in abnehmbare und schiebbare Spulen unterteilt Spule. Im Jahr 2021 hatte das Segment der abnehmbaren Spulen einen größeren Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment im Prognosezeitraum mit einer signifikanten CAGR wächst. Abnehmbare Coils benötigen weniger Zeit für das Verfahren als schiebbare Coils und sind als weiche oder standardisierte Coils gekennzeichnet, die für Aneurysmen und Gefäße in verschiedenen klinischen Anwendungen verwendet werden. Die Spulen werden mit einem mechanischen Ablösegriff mit einem Klick platziert.



Globaler Markt für Embolisationsspulen nach Typ – 2022 und 2028



Globaler Markt für Embolisationsspulen, nach Typ – 2022 und 2028Anwendung Einblicke

Basierend auf der Anwendung, dem weltweiten Markt für Embolisationsspulen ist in Neurologie, Kardiologie, Urologie, Onkologie, periphere Gefäßerkrankungen und andere unterteilt. Im Jahr 2021 hatte das Segment Neurologie den größten Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment in den kommenden Jahren am schnellsten wachsen wird. Embolisationsspulen werden im Allgemeinen zur Behandlung von Hirnaneurysmen und arteriovenösen Malformationen (AVMs) in der Neurologie eingesetzt. Eine AVM ist ein Gewirr von Blutgefäßen, die Arterien und Venen verbinden, das den Blutfluss und die Sauerstoffzirkulation stört, was zu Sauerstoffmangel für das umgebende Gewebe führt.



Material Insights



Basierend auf dem Material ist der globale Markt für Embolisationsspiralen in Platin, Platin & Hydrogel und Platin-Wolfram-Legierung. Das Platinsegment hatte 2021 den größten Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment von 2022 bis 2028 die höchste CAGR verzeichnen wird.



Erkenntnisse der Endnutzer



Basierend auf dem Endverbraucher ist der globale Markt für Embolisationsspulen in Krankenhäuser, Herzzentren, ambulante Zentren und andere unterteilt. Das Krankenhaussegment hatte 2021 den größten Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment von 2022 bis 2028 die höchste CAGR verzeichnen wird.



Anorganische Entwicklungen wie Fusionen und Übernahmen sind weit verbreitete Strategien von Unternehmen auf dem globalen Markt für Embolisationsspulen. Nachfolgend sind einige der wichtigsten Marktentwicklungen der letzten Zeit aufgeführt:



  • Im Mai 2019 erhält Shape Memory Medical die PMDA-Zulassung für den IMPEDE-FX Embolisationsstecker.
  • Im Dezember 2019 bringt Kaneka eine neue Spule zur Embolisation von Hirnaneurysmen auf den Markt.
  • Im August 2022, Boston Scientific Die Corporation BSX gab die Übernahme von Obsidio, Inc. bekannt. Es handelt sich um ein Unternehmen in Privatbesitz, das der renommierte Entwickler der von der FDA zugelassenen Gelemboliematerial-Technologie (GEM) ist.

Firmenprofile



  • Terumo Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • Stryker Corporation
  • KANEKA CORPORATION
  • MicroPort Scientific Corporation
  • Penumbra, Inc
  • Cook Medical LLC
  • Johnson & Johnson Services, Inc.
  • Shape Memory Medical INC,
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is an embolization coil?

Coil embolization describes a minimally invasive surgical procedure for the treatment of cerebral aneurysms and fistulas. A tiny coil is passed to the brain through a catheter inserted in the groin and disconnected from the catheter to prevent blood flow to the aneurysm or fistula. One or more platinum coils are left in place to prevent the aneurysm from rupturing. Reduced blood flow to the brain can impair binocular vision.

What are the driving factors for the global embolization coil market across the globe?

The number of minimally invasive surgeries is rising as patients increasingly prefer such surgeries due to lesser postoperative pain, postoperative complications, shorter hospital stays, fast recovery times, etc. Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. For instance, Trans Arterial Chemo Embolization, also known as TACE, is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma

Who are the major players in the embolization coil market across the globe?

The embolization coil market majorly consists of the players, such as Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker Corporation; Johnson & Johnson; Cook Medical; Penumbra, Inc; Kaneka Corporation; Shape Memory Medical INC; and Microport Scientific Corporation

What is the market CAGR value of the embolization coil market during the forecast period?

The CAGR value of the embolization coil market during the forecasted period of 2022-2028 is 4.3%.

What is the estimated embolization coil market size in 2021?

The embolization coil market is estimated to be valued at US$ 1,191.78 million in 2021.

What are the growth estimates for the embolization coil market till 2028?

The embolization coil market is expected to be valued at US$ 1,591.60 million in 2028.

Which product led the embolization coil market?

The detachable coil held the largest share of the market in the global embolization coil market contributing a market share of US$ 686.47 million in 2021.

Which region is projected to be the fastest-growing region in the global embolization market?

The Asia Pacific is expected to be the fastest-growing region in the embolization market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and lifestyle diseases in these regions will show promising growth in the embolization market.

The List of companies - Embolization Coils Market.

  1. Terumo Corporation
  2. Medtronic
  3. Boston Scientific Corporation
  4. Stryker
  5. Johnson & Johnson Services, Inc
  6. Cook Medical LLC
  7. Penumbra, Inc
  8. KANEKA CORPORATION
  9. Shape Memory Medical INC
  10. Microport Scientific Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports